Jason Carroll completed a PhD in 2002 at the University of New South Wales and the Garvan Institute, Sydney, with Prof Robert Sutherland. He conducted postdoctoral work with Prof. Myles Brown at Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA. He has been running his own group at Cancer Research UK, Cambridge Institute and University of Cambridge since 2007. He is currently a Professor of Molecular Oncology, University of Cambridge, a senior group leader at Cancer Research UK, a Fellow at Clare College and the Founder and CSO of Azeria Therapeutics. His lab is interested in understanding mechanisms of hormone-dependent cancer.